nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg searchdiv qikanlogo popupnotification paper
2025 02 v.60 187-194
长链非编码RNA LUCAT1调控胰腺癌MIA PaCa-2细胞恶性机制研究
基金项目(Foundation): 国家自然科学基金(编号:82002534); 安徽省转化医学研究院科研基金(编号:2022zhyx-C71)~~
邮箱(Email): luoguangtao@outlook.com;
DOI: 10.19405/j.cnki.issn1000-1492.2025.02.001
中文作者单位:

安徽医科大学附属第一医院乳腺外科;

摘要(Abstract):

目的 探究长链非编码RNA(lncRNA)LUCAT1对人胰腺癌细胞MIA PaCa-2生物学行为的影响,探讨LUCAT1在胰腺癌恶性进展中的潜在作用。方法 在线数据库GEPIA分析LUCAT1在胰腺癌中的突变及表达情况;q-PCR实验检测对比人胰腺导管细胞HPNE及人胰腺癌细胞中LUCAT1的表达水平;FISH检测人胰腺癌组织中LUCAT1表达及分布。CCK-8实验和Transwell实验检测LUCAT1对MIA PaCa-2细胞增殖、凋亡、耐药及迁移能力的影响。基因集合富集分析比对LUCAT1参与的相关信号通路,Western blot实验验证蛋白质表达水平。结果 GEPIA分析结果显示,LUCAT1在人胰腺癌组织中表达水平上调;q-PCR实验结果显示,人胰腺癌细胞中LUCAT1高表达,差异有统计学意义(P<0.05)。敲低及过表达LUCAT1可影响胰腺癌细胞增殖、凋亡、吉西他滨耐药性以及迁移和侵袭能力(P<0.05)。在胰腺癌中LUCAT1影响p-Akt表达水平,并在Akt抑制剂MK-2206处理后相关功能被抑制。结论 LUCAT1通过PI3K-Akt信号通路调控胰腺癌细胞MIA PaCa-2恶性进展。

关键词(KeyWords): 长链非编码RNA;LUCAT1;胰腺癌;MIA PaCa-2;肿瘤耐药;Akt
参考文献

[1] Giaquinto A N,Miller K D,Tossas K Y,et al.Cancer statistics for African American/black people 2022[J].CA Cancer J Clin,2022,72(3):202-29.doi:10.3322/caac.21718.

[2] Rahib L,Smith B D,Aizenberg R,et al.Projecting cancer incidence and deaths to 2030:the unexpected burden of thyroid,liver,and pancreas cancers in the United States[J].Cancer Res,2014,74(11):2913-21.doi:10.1158/0008-5472.CAN-14-0155.

[3] Slack F J,Chinnaiyan A M.The role of non-coding RNAs in oncology[J].Cell,2019,179(5):1033-55.doi:10.1016/j.cell.2019.10.017.

[4] Shen X,Zhang Y,Wu X,et al.Upregulated lncRNA-PCAT1 is closely related to clinical diagnosis of multiple myeloma as a predictive biomarker in serum[J].Cancer Biomark,2017,18(3):257-63.doi:10.3233/CBM-160158.

[5] Xing C,Sun S G,Yue Z Q,et al.Role of lncRNA LUCAT1 in cancer[J].Biomed Pharmacother,2021,134:111158.doi:10.1016/j.biopha.2020.111158.

[6] Sun Y,Jin S D,Zhu Q,et al.Long non-coding RNA LUCAT1 is associated with poor prognosis in human non-small lung cancer and regulates cell proliferation via epigenetically repressing p21 and p57 expression[J].Oncotarget,2017,8(17):28297-311.doi:10.18632/oncotarget.16044.

[7] Yoon J H,You B H,Park C H,et al.The long noncoding RNA LUCAT1 promotes tumorigenesis by controlling ubiquitination and stability of DNA methyltransferase 1 in esophageal squamous cell carcinoma[J].Cancer Lett,2018,417:47-57.doi:10.1016/j.canlet.2017.12.016.

[8] Zheng A,Song X,Zhang L,et al.Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/β-catenin pathway[J].J Exp Clin Cancer Res,2019,38(1):305.doi:10.1186/s13046-019-1315-8.

[9] Zhou Q,Hou Z,Zuo S,et al.LUCAT1 promotes colorectal cancer tumorigenesis by targeting the ribosomal protein L40-MDM2-p53 pathway through binding with UBA52[J].Cancer Sci,2019,110(4):1194-207.doi:10.1111/cas.13951.

[10] 骆广涛,汤为香,裘正军.低氧条件下Akt抑制剂MK-2206增强胰腺癌细胞对吉西他滨敏感性的作用研究[J].安徽医科大学学报,2020,55(2):166-71.doi:10.19405/j.cnki.issn1000-1492.2020.02.003.[10] Luo G T,Tang W X,Qiu Z J.Mechanism of Akt inhibitor MK-2206 in enhancing the sensitivity of pancreatic cancer cells to gemcitabine under hypoxia[J].Acta Univ Med Anhui,2020,55(2):166-71.doi:10.19405/j.cnki.issn1000-1492.2020.02.003.

[11] Wang X,Guo S,Zhao R,et al.STAT3-Activated long non-coding RNA lung cancer associated transcript 1 drives cell proliferation,migration,and invasion in hepatoblastoma through regulation of the miR-301b/STAT3 axis[J].Hum Gene Ther,2019,30(6):702-13.doi:10.1089/hum.2018.146.

[12] Cao W,Zhang H F,Ding X L,et al.The progression of pancreatic cancer cells is promoted by a long non-coding RNA LUCAT1 by activating AKT phosphorylation[J].Eur Rev Med Pharmacol Sci,2021,25(2):738-48.doi:10.26355/eurrev_202101_24635.

[13] Huan L,Guo T,Wu Y,et al.Hypoxia induced LUCAT1/PTBP1 axis modulates cancer cell viability and chemotherapy response[J].Mol Cancer,2020,19(1):11.doi:10.1186/s12943-019-1122-z.

[14] Lou Y,Yu Y,Xu X,et al.Long non-coding RNA LUCAT1 promotes tumourigenesis by inhibiting ANXA2 phosphorylation in hepatocellular carcinoma[J].J Cell Mol Med,2019,23(3):1873-84.doi:10.1111/jcmm.14088.

[15] Xu F,Huang M,Chen Q,et al.LncRNA HIF1A-AS1 promotes gemcitabine resistance of pancreatic cancer by enhancing glycolysis through modulating the AKT/YB1/HIF1α pathway[J].Cancer Res,2021,81(22):5678-91.doi:10.1158/0008-5472.CAN-21-0281.

[16] Huan L,Guo T,Wu Y,et al.Hypoxia induced LUCAT1/PTBP1 axis modulates cancer cell viability and chemotherapy response[J].Mol Cancer,2020,19(1):11.doi:10.1186/s12943-019-1122-z.

基本信息:

DOI:10.19405/j.cnki.issn1000-1492.2025.02.001

中图分类号:R735.9

引用信息:

[1]叶梦洁,瞿薇薇,骆广涛.长链非编码RNA LUCAT1调控胰腺癌MIA PaCa-2细胞恶性机制研究[J].安徽医科大学学报,2025,60(02):187-194.DOI:10.19405/j.cnki.issn1000-1492.2025.02.001.

基金信息:

国家自然科学基金(编号:82002534); 安徽省转化医学研究院科研基金(编号:2022zhyx-C71)~~

检 索 高级检索

引用

GB/T 7714-2015 格式引文
MLA格式引文
APA格式引文